Cortexyme Inc.

NASDAQ: CRTX · Real-Time Price · USD
1.95
0.05 (2.63%)
At close: Aug 01, 2022, 6:00 AM

Cortexyme Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Cash & Equivalents
69.72M
Short-Term Investments
37.08M
Long-Term Investments
19.93M
Other Long-Term Assets
194K
Receivables
n/a
Inventory
n/a
Other Current Assets
4.87M
Total Current Assets
111.67M
Property-Plant & Equipment
1.43M
Goodwill & Intangibles
n/a
Total Long-Term Assets
21.55M
Total Assets
133.23M
Account Payables
4.91M
Deferred Revenue
n/a
Short-Term Debt
n/a
Other Current Liabilities
9.31M
Total Current Liabilities
14.22M
Long-Term Debt
420K
Other Long-Term Liabilities
n/a
Total Long-Term Liabilities
420K
Total Liabilities
14.64M
Total Debt
420K
Common Stock
30K
Retained Earnings
-236.6M
Comprehensive Income
-79K
Shareholders Equity
118.59M
Total Investments
57.01M